Suppr超能文献

同种异体反应性T细胞应答以及单一II类主要组织相容性复合体(MHC)不相合心脏移植的急性排斥反应受到CD4+ CD25+ T细胞的严格调控。

Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4+ CD25+ T cells.

作者信息

Schenk Soren, Kish Danielle D, He Chunshui, El-Sawy Tarek, Chiffoleau Eise, Chen Chuangqi, Wu Zihao, Sandner Sigrid, Gorbachev Anton V, Fukamachi Kiyotaka, Heeger Peter S, Sayegh Mohamed H, Turka Laurence A, Fairchild Robert L

机构信息

Department of Biomedical Engineering, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

出版信息

J Immunol. 2005 Mar 15;174(6):3741-8. doi: 10.4049/jimmunol.174.6.3741.

Abstract

Skin but not vascularized cardiac allografts from B6.H-2bm12 mice are acutely rejected by C57BL/6 recipients in response to the single class II MHC disparity. The underlying mechanisms preventing acute rejection of B6.H-2bm12 heart allografts by C57BL/6 recipients were investigated. B6.H-2bm12 heart allografts induced low levels of alloreactive effector T cell priming in C57BL/6 recipients, and this priming was accompanied by low-level cellular infiltration into the allograft that quickly resolved. Recipients with long-term-surviving heart allografts were unable to reject B6.H-2bm12 skin allografts, suggesting potential down-regulatory mechanisms induced by the cardiac allografts. Depletion of CD25+ cells from C57BL/6 recipients resulted in 15-fold increases in alloreactive T cell priming and in acute rejection of B6.H-2bm12 heart grafts. Similarly, reconstitution of B6.Rag(-/-) recipients with wild-type C57BL/6 splenocytes resulted in acute rejection of B6.H-2bm12 heart grafts only if CD25+ cells were depleted. These results indicate that acute rejection of single class II MHC-disparate B6.H-2bm12 heart allografts by C57BL/6 recipients is inhibited by the emergence of CD25+ regulatory cells that restrict the clonal expansion of alloreactive T cells.

摘要

来自B6.H-2bm12小鼠的皮肤而非血管化心脏同种异体移植物,会因单一的II类主要组织相容性复合体差异而被C57BL/6受体急性排斥。研究了C57BL/6受体阻止急性排斥B6.H-2bm12心脏同种异体移植物的潜在机制。B6.H-2bm12心脏同种异体移植物在C57BL/6受体中诱导低水平的同种异体反应性效应T细胞致敏,并且这种致敏伴随着同种异体移植物中低水平的细胞浸润,而这种浸润很快就会消退。心脏同种异体移植物长期存活的受体无法排斥B6.H-2bm12皮肤同种异体移植物,这表明心脏同种异体移植物诱导了潜在的下调机制。从C57BL/6受体中清除CD25+细胞导致同种异体反应性T细胞致敏增加15倍,并导致B6.H-2bm12心脏移植物急性排斥。同样,用野生型C57BL/6脾细胞重建B6.Rag(-/-)受体,只有在清除CD25+细胞时才会导致B6.H-2bm12心脏移植物急性排斥。这些结果表明,C57BL/6受体对单一II类主要组织相容性复合体不同的B6.H-2bm12心脏同种异体移植物的急性排斥,受到限制同种异体反应性T细胞克隆扩增的CD25+调节细胞出现的抑制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验